The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tiziana Life Sciences Issues GBP1.4 Million Convertible Loan Notes

Fri, 01st Nov 2019 17:31

(Alliance News) - Tiziana Life Sciences PLC said Friday it raised GBP1.4 million through the issue of convertible unsecured loan notes to fund working capital needs.

Tiziana had originally intended to raise funds through the issue of its Nasdaq-listed shares.

"However, the directors decided that given current market conditions, such an equity fundraise would be on dilutive terms which would be punitive to existing shareholders particularly in light of the recent positive news from the company's scientific programs," Tiziana said in a statement. "Accordingly, the company has decided to raise convertible debt finance from supportive existing shareholders."

The convertible notes will carry a 16% per year interest coupon and will be convertible at a price of 42 pence each. Shares in Tiziana closed untraded at 47.00 pence in London on Friday.

Tiziana emphasised the notes were only expected to be "short-term" financial instruments.

In addition, each convertible loan note comes with a warrant to purchase another share at 42p each anytime over the next five years.

By Ahren Lester; ahrenlester@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
18 Jul 2016 08:46

Tiziana Life Buys Gene Samples Of Long-Lifed Sardinian Community

Read more
24 Jun 2016 09:49

WINNERS & LOSERS SUMMARY: Gold, Dollar Exposure Rewarded Post-Brexit

Read more
24 Jun 2016 07:44

UPDATE: UK Chemicals And Pharmaceuticals Must "Look To Future"

Read more
23 Jun 2016 15:08

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 08:27

Tiziana Life Sciences 2015 Loss Widens As It Progresses Candidates

Read more
1 Jun 2016 14:49

Tiziana partnership scoops innovation award

(ShareCast News) - Clinical stage biotechnology company Tiziana Life Sciences was celebrating on Wednesday, after its partnership with researchers at Cardiff University collected a fresh award. The AIM-traded company said the partnership, which has led to the development of a potential new drug for

Read more
19 May 2016 10:13

Tiziana Life Sciences Says Its Antibody Foralumab Featured In Review

Read more
4 Apr 2016 07:36

Tiziana Life Sciences Appoints Tiziano Lazzaretti As Finance Chief

Read more
4 Apr 2016 07:32

Tiziana Life Sciences appoints new CFO

(ShareCast News) - Tiziana Life Sciences has appointed Tiziano Lazzaretti as Chief Financial Officer, effective immediately. Confirming the move on Monday, the AIM-listed biotechnology company said the appointment was not a board level position. Lazzaretti has extensive experience in the healthcare

Read more
13 Jan 2016 09:53

Tiziana Life Sciences Raises Funds Via Convertible Loan Note Issue (ALLISS)

Read more
11 Jan 2016 09:17

Tiziana To Focus Foralumab Development On Two Clinical Applications

Read more
8 Jan 2016 08:35

Tiziana reveals possible new anti-cancer molecule

(ShareCast News) - Tiziana Life Sciences revealed the great strides it had made in the quest for cancer-fighting drugs this week, as part of its research partnership with the Cardiff University / Prifysgol Caerdydd. The AIM-listed biotechnology company, which focuses on targeted drugs to treat disea

Read more
8 Jan 2016 07:54

Tiziana Identifies New Potential Cancer Drug With Cardiff University

Read more
9 Dec 2015 09:20

Tiziana Life Sciences Appoints James Tripp Chief Operating Officer

Read more
8 Dec 2015 10:04

Tiziana Life Sciences Raises GBP3.8 Million Via Convertible Note Issue (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.